Paul Crispen, MD, discusses the Bladder Preservation program at Uf Health Shands Hospital. He examines current indications for radical cycstectomy when treating bladder cancer. He helps us to understand the current indications for radical cycstectomy when treating bladder cancer.

He defines BCG refractory disease and treatment options outside of radical cystectomy for BCG refractory disease, and very importantly he shares patient and tumor characteristics that are associated with improved outcomes.